Skip to content

Effects of general anaesthesia with remimazolam tosilate on hemodynamic profiles and the postoperative functional recovery in adults: a pragmatic clinical trial

Effects of general anaesthesia with remimazolam tosilate on hemodynamic profiles and the postoperative functional recovery in adults:a pragmatic clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062520
Enrollment
Unknown
Registered
2022-08-10
Start date
2022-08-15
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension

Interventions

RE group:remimazolam tosilate plus ERAS
PE group:propofol plus ERAS

Sponsors

Guangdong Provincial Peoples Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) male or female aged =18 years old; (2) ASA-PS score of 1–3; (3) scheduled for an elective surgical procedure under GA, including general surgery, thoracic surgery and other sergeries (urological surgery, otolaryngology etc.); (4) scheduled for endotracheal insert removal and planning to return to the ward after surgery; and (5) confirmed ICF signature.

Exclusion criteria

Exclusion criteria: (1) patient or their legally authorized representative refuses to participate in the study; (2) disorder of consciousness due to severe neurological or mental system diseases or other causes; (3) inability to communicate due to low level of education or a language barrier; (4) alcohol or drug abuse or dependence; (5) allergy to benzodiazepine or contraindications; (6) enrolment in other clinical trials within the last 3 months; (7) participation in the trial is not considered appropriate by the researchers.

Design outcomes

Primary

MeasureTime frame
the 24-hour postoperative quality of recovery-40 score;the rate of intraoperative hypotension;

Secondary

MeasureTime frame
the 72-hour postoperative quality of recovery-40 score;the rate of sedative hypotension requiring treatment;anesthetic hemodynamic profiles;the incidence of delirium within 1 day;incidence of main cardiovascular-related adverse events within 30 days;lung events within 30 day;the rates of surgery-related complications within 30 day;the rate of acute kidney injury in hospital;the rate of emergency readmission within 30 day;the surgery-related mortality within 3 months;the quality of life within 3 months;the functional anesthetic capability;

Countries

China

Contacts

Public ContactShu Haihua

Guangdong Provincial People's Hospital

shuhaihua@hotmail.com+86 134 2753 6899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026